Skip to search formSkip to main contentSkip to account menu

Gram per Square Meter per Day

Known as: Gram per Square Meter per 24 Hours, g/m2/d, g/m2/day 
Dose of drug administered per day expressed as grams per square meter of body surface area (BSA).
National Institutes of Health

Related topics

Related topics

1 relation
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Determining Permissible Oxygen and Water Vapor Transmission Rate for Non-Retort Military Ration Packaging
Abstract : This report documents a study that was conducted by the Department of Defense (DoD) Combat Feeding Directorate at the… 
2005
2005
Phase I Dose Deescalation Trial of a-Difluoromethylornithine in Patients with Grade 3 Cervical Intraepithelial Neoplasia ’
a-Difluoromethylornithine (DFMO) is a suicide inhibitor of ornithine decarboxylase and potent antiproliferative chemopreventive… 
2002
2002
STUDIES OF PASSIVE TREATMENT SYSTEMS : VERTICAL FLOW SYSTEMS
As part of the Acid Drainage Technology Initiative (ADTI), case studies of 30 vertical flow systems (VFS or SAPS) have been… 
1995
1995
A Phase I and II Trial of Dose‐Intensified Cyclophosphamide and GM‐CSF in Pediatric Malignant Brain Tumors
Purpose Cyclophosphamide is commonly used in the treatment of children with malignant brain tumors. The purpose of this study was… 
1991
1991
Sediment trap study in the Green Bay mass balance program : mass and organic carbon fluxes, resuspension, and particle settling velocities
This research is a part of a large, multidisciplinary program designed to measure and model the mass balance of congener-specific… 
Review
1989
Review
1989
[Specific cardiomyopathy caused by high dose cyclophosphamide immediately after bone marrow transplantation].
An 11-year-old girl with CML in chronic phase was treated with allogeneic bone marrow transplantation (BMT). She had had no… 
1986
1986
Phase I clinical and pharmacological study of thymidine (NSC 21548) and cis-diamminedichloroplatinum(II) in patients with advanced cancer.
Studies in cell culture systems have demonstrated synergistic cytotoxicity of thymidine and its in vivo metabolite thymine with… 
1985
1985
Treatment of refractory leukemia with high-dose cytosine arabinoside.
Thirteen patients with refractory acute nonlymphocytic leukemia or with accelerated phase of chronic myeloid leukemia have been… 
1983
1983
Phase I evaluation of oral tegafur.
A phase I clinical study of tegafur (ftorafur) was conducted in 29 patients with various advanced solid tumors. To evaluate its… 
Review
1981
Review
1981
Clinical trials with diglycoaldehyde (NSC-118994): review and reasons for withdrawal from clinical trial.
All Phase II studies with diglycoaldehyde with leukemia and solid tumors have been reviewed. The dose schedules employed ranged…